Menu
← Oncology Approval Tracker
FDA DECISION ·
Keytruda + pemetrexed + platinum
pembrolizumab with pemetrexed and platinum chemotherapy · Merck
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First-line treatment of unresectable advanced or metastatic malignant pleural mesothelioma with pembrolizumab, pemetrexed and platinum chemotherapy.
LAMPGEN ANALYSIS
Why it matters
The decision adds a chemoimmunotherapy option for advanced pleural mesothelioma alongside other regimen choices.
What research teams should watch
Ensure pathology subtype and baseline imaging are available, and align pleural tumor measurements and supportive medication schedules.
PRIMARY RECORDS